Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.

Kamlesh Khunti F MedSciThomas R GodecJesús MedinaLaura Garcia-AlvarezJosh HillerMarilia B GomesJavier Cid-RuzafaBernard CharbonnelPeter FeniciNiklas HammarKiyoshi HashigamiMikhail KosiborodAntonio NicolucciMarina V ShestakovaLi-Nong JiStuart Pocock

Published in: Diabetes, obesity & metabolism (2017)

Many patients with T2DM have very high HbA1c levels when initiating second-line therapy, indicating the need for earlier treatment intensification. Patient-specific factors merit consideration when making treatment decisions.

Keyphrases

type diabetes
combination therapy
cross sectional
electronic health record
mesenchymal stem cells
replacement therapy
big data
glycemic control